APA (7th ed.) Citation

L, Z., M, W., U, P., J, S., K, I., L, R., . . . M, S. (2023). Actionable loss of SLF2 drives B-cell lymphomagenesis and impairs the DNA damage response. EMBO molecular medicine, 15(9), e16431. https://doi.org/10.15252/emmm.202216431

Chicago Style (17th ed.) Citation

L, Zhang, et al. "Actionable Loss of SLF2 Drives B-cell Lymphomagenesis and Impairs the DNA Damage Response." EMBO Molecular Medicine 15, no. 9 (2023): e16431. https://doi.org/10.15252/emmm.202216431.

MLA (9th ed.) Citation

L, Zhang, et al. "Actionable Loss of SLF2 Drives B-cell Lymphomagenesis and Impairs the DNA Damage Response." EMBO Molecular Medicine, vol. 15, no. 9, 2023, p. e16431, https://doi.org/10.15252/emmm.202216431.